Tissue factor pathway inhibitor in thrombosis and beyond.

Methods in molecular medicine

Volumn 93, Issue , 2004, Pages 133-155

  Mousa, Shaker A ^a   Fareed, Jawed ^a   Iqbal, Omer ^a   Kaiser, Brigitte ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; LIPOPROTEIN; LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL; ARTERIOSCLEROSIS; BLOOD; BLOOD CLOTTING; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; DRUG INTERACTION; HEART INFARCTION; HUMAN; IN VITRO STUDY; PHYSIOLOGY; REVIEW; SEPSIS; THROMBOSIS; UNSTABLE ANGINA PECTORIS; VASCULAR SMOOTH MUSCLE;

ANGINA, UNSTABLE; ANIMALS; ANTICOAGULANTS; ARTERIOSCLEROSIS; BLOOD COAGULATION; DISSEMINATED INTRAVASCULAR COAGULATION; DRUG INTERACTIONS; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LIPOPROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL INFARCTION; SEPSIS; THROMBOSIS;

EID: 1842828919     PISSN: 15431894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)